SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-24-000062
Filing Date
2024-02-06
Accepted
2024-02-06 17:00:22
Documents
1
Period of Report
2024-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 02-05-2024 form4.html 4  
1 FORM 4 FOR 02-05-2024 form4.xml 4 5448
  Complete submission text file 0001161697-24-000062.txt   7158
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address
DENKHAUS DONALD A (Reporting) CIK: 0001278439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 24601043

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)